Loading viewer...
investor_presentation
Format: PDF investor_presentation
MIRA Pharmaceuticals, Inc. IPO prospectus for July 2023 offering on NASDAQ Capital Market at $7.00 per share. The company is developing early-stage preclinical pharmaceutical product candidates with proceeds directed toward clinical development and general corporate purposes.
investor_presentation
Vistra Corporation
20 Pages
AGBA Group 2023 Investor Presentation
investor_presentationinvestor_presentation
34 Pages
AGBA Group Holding Limited
Regeneron Pharmaceuticals Investor Presentation — June 2019
investor_presentationinvestor_presentation
25 Pages
Regeneron Pharmaceuticals, Inc.